Jupiter Neurosciences (JUNS) Other Non-Current Assets (2023 - 2025)
Jupiter Neurosciences (JUNS) posted quarterly Other Non-Current Assets of $712055.0 for Q4 2025, down 51.85% year-over-year from $1.5 million in Q4 2024, and down 21.35% quarter-over-quarter from $905297.0 in Q3 2025.
Jupiter Neurosciences (JUNS) Other Non-Current Assets (2023 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Other Non-Current Assets for 3 consecutive years, with $712055.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Non-Current Assets fell 51.85% year-over-year to $712055.0; the TTM figure through Dec 2025 stood at $712055.0 (down 51.85% YoY), while the FY2025 annual figure was $712055.0, down 51.85% from the prior year.
- Other Non-Current Assets declined to $712055.0 in Q4 2025 per JUNS's latest filing, from $905297.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.5 million in Q4 2024 and bottomed at $3783.0 in Q4 2023.
- Historically, Other Non-Current Assets has averaged $628157.4 across 3 years, with a median of $712055.0 in 2025.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 38988.58% — and 2025, when it slumped 51.85%.
- Jupiter Neurosciences' Other Non-Current Assets stood at $3783.0 in 2023, then jumped by 38988.58% to $1.5 million in 2024, then tumbled by 51.85% to $712055.0 in 2025.
- Business Quant data shows JUNS's Other Non-Current Assets at $712055.0 in Q4 2025, $905297.0 in Q3 2025, and $3783.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Jupiter Neurosciences | 3.37 Mn | 1.85 Mn | 21,064.00 | 618,058.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 712,055.00 |
| Sep 30, 2025 | 905,297.00 |
| Jun 30, 2025 | 3,783.00 |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 3,783.00 |
| Dec 31, 2023 | 3,783.00 |